Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer

Daisuke Yamada, Kensuke Takahashi, Kohichi Kawahara, Takehiko Maeda

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cancer stem-like cells (CSCs) exist in tumor tissues composed of heterogeneous cell population and are characterized by their self-renewal capacity and tumorigenicity. Many studies demonstrate that eradication of CSCs prevents development and recurrences of tumor; yet, molecules critical for the maintenance of CSCs have not been completely understood. We previously reported that Semaphorin3A (Sema3a) knockdown suppressed the tumorigenicity and proliferative capacity of Lewis lung carcinoma (LLC) cells. Therefore, we identified Sema3a as an essential factor for the establishment or maintenance of CSCs derived from LLC (LLC-stem cell). shRNA against Sema3a was introduced into LLC cells to establish a LLC-stem cell line and its effects on tumorigenesis, sphere formation, and mTORC1 activity were tested. Sema3a knockdown completely abolished tumorigenicity and the sphere-formation and self-renewal ability of LLC-stem cells. The Sema3a knockdown was also associated with decreased expression of mRNA for stem cell markers. The self-renewal ability abolished by Sema3a knockdown could not be recovered by exogenous addition of recombinant SEMA3A. In addition, the activity of mammalian target of rapamycin complex 1 (mTORC1) and the expression of its substrate p70S6K1 were also decreased. These results demonstrate that Sema3a is a potential therapeutic target in eradication of CSCs.

Original languageEnglish
Pages (from-to)375-379
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume480
Issue number3
DOIs
Publication statusPublished - Nov 18 2016
Externally publishedYes

Fingerprint

Autocrine Communication
Lewis Lung Carcinoma
Stem cells
Neoplastic Stem Cells
Lung Neoplasms
Stem Cells
Maintenance
Tumors
Cells
Small Interfering RNA
Tissue
Messenger RNA
Molecules
Neoplasms
Carcinogenesis
Substrates
Recurrence
Cell Line
Population

Keywords

  • Cancer stem-like cell
  • Lung cancer
  • mTOR signaling
  • Semaphorin3A

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer. / Yamada, Daisuke; Takahashi, Kensuke; Kawahara, Kohichi; Maeda, Takehiko.

In: Biochemical and Biophysical Research Communications, Vol. 480, No. 3, 18.11.2016, p. 375-379.

Research output: Contribution to journalArticle

@article{e5c366bcf66a420f807c98ee40d9cee8,
title = "Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer",
abstract = "Cancer stem-like cells (CSCs) exist in tumor tissues composed of heterogeneous cell population and are characterized by their self-renewal capacity and tumorigenicity. Many studies demonstrate that eradication of CSCs prevents development and recurrences of tumor; yet, molecules critical for the maintenance of CSCs have not been completely understood. We previously reported that Semaphorin3A (Sema3a) knockdown suppressed the tumorigenicity and proliferative capacity of Lewis lung carcinoma (LLC) cells. Therefore, we identified Sema3a as an essential factor for the establishment or maintenance of CSCs derived from LLC (LLC-stem cell). shRNA against Sema3a was introduced into LLC cells to establish a LLC-stem cell line and its effects on tumorigenesis, sphere formation, and mTORC1 activity were tested. Sema3a knockdown completely abolished tumorigenicity and the sphere-formation and self-renewal ability of LLC-stem cells. The Sema3a knockdown was also associated with decreased expression of mRNA for stem cell markers. The self-renewal ability abolished by Sema3a knockdown could not be recovered by exogenous addition of recombinant SEMA3A. In addition, the activity of mammalian target of rapamycin complex 1 (mTORC1) and the expression of its substrate p70S6K1 were also decreased. These results demonstrate that Sema3a is a potential therapeutic target in eradication of CSCs.",
keywords = "Cancer stem-like cell, Lung cancer, mTOR signaling, Semaphorin3A",
author = "Daisuke Yamada and Kensuke Takahashi and Kohichi Kawahara and Takehiko Maeda",
year = "2016",
month = "11",
day = "18",
doi = "10.1016/j.bbrc.2016.10.057",
language = "English",
volume = "480",
pages = "375--379",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancer

AU - Yamada, Daisuke

AU - Takahashi, Kensuke

AU - Kawahara, Kohichi

AU - Maeda, Takehiko

PY - 2016/11/18

Y1 - 2016/11/18

N2 - Cancer stem-like cells (CSCs) exist in tumor tissues composed of heterogeneous cell population and are characterized by their self-renewal capacity and tumorigenicity. Many studies demonstrate that eradication of CSCs prevents development and recurrences of tumor; yet, molecules critical for the maintenance of CSCs have not been completely understood. We previously reported that Semaphorin3A (Sema3a) knockdown suppressed the tumorigenicity and proliferative capacity of Lewis lung carcinoma (LLC) cells. Therefore, we identified Sema3a as an essential factor for the establishment or maintenance of CSCs derived from LLC (LLC-stem cell). shRNA against Sema3a was introduced into LLC cells to establish a LLC-stem cell line and its effects on tumorigenesis, sphere formation, and mTORC1 activity were tested. Sema3a knockdown completely abolished tumorigenicity and the sphere-formation and self-renewal ability of LLC-stem cells. The Sema3a knockdown was also associated with decreased expression of mRNA for stem cell markers. The self-renewal ability abolished by Sema3a knockdown could not be recovered by exogenous addition of recombinant SEMA3A. In addition, the activity of mammalian target of rapamycin complex 1 (mTORC1) and the expression of its substrate p70S6K1 were also decreased. These results demonstrate that Sema3a is a potential therapeutic target in eradication of CSCs.

AB - Cancer stem-like cells (CSCs) exist in tumor tissues composed of heterogeneous cell population and are characterized by their self-renewal capacity and tumorigenicity. Many studies demonstrate that eradication of CSCs prevents development and recurrences of tumor; yet, molecules critical for the maintenance of CSCs have not been completely understood. We previously reported that Semaphorin3A (Sema3a) knockdown suppressed the tumorigenicity and proliferative capacity of Lewis lung carcinoma (LLC) cells. Therefore, we identified Sema3a as an essential factor for the establishment or maintenance of CSCs derived from LLC (LLC-stem cell). shRNA against Sema3a was introduced into LLC cells to establish a LLC-stem cell line and its effects on tumorigenesis, sphere formation, and mTORC1 activity were tested. Sema3a knockdown completely abolished tumorigenicity and the sphere-formation and self-renewal ability of LLC-stem cells. The Sema3a knockdown was also associated with decreased expression of mRNA for stem cell markers. The self-renewal ability abolished by Sema3a knockdown could not be recovered by exogenous addition of recombinant SEMA3A. In addition, the activity of mammalian target of rapamycin complex 1 (mTORC1) and the expression of its substrate p70S6K1 were also decreased. These results demonstrate that Sema3a is a potential therapeutic target in eradication of CSCs.

KW - Cancer stem-like cell

KW - Lung cancer

KW - mTOR signaling

KW - Semaphorin3A

UR - http://www.scopus.com/inward/record.url?scp=84994275497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994275497&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2016.10.057

DO - 10.1016/j.bbrc.2016.10.057

M3 - Article

C2 - 27769863

AN - SCOPUS:84994275497

VL - 480

SP - 375

EP - 379

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -